Company intelligence / Profile preview

Medisol Lifescience

Aklara (Umargam, Valsad district), Gujarat, India

Ownership: Private
Employees: ~80
Development stage: Other

Overview

Medisol Lifescience is a WHO-GMP certified Indian pharmaceutical company specializing in the manufacture of generic inhaled therapies for asthma and COPD, operating as a unit of the Asian Aerosol group. Its facilities are cGMP-compliant and its product portfolio includes metered-dose inhalers for both adults and children.

Therapeutic areas: Pulmonology
Modalities: Small molecule
Industry: Biotech

Drug pipeline

2 assets

SALFLUSOL

Approved

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Medisol Lifescience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medisol Lifescience.

Explore the full profile